M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.52 EUR -3.34% Market Closed
Market Cap: 104.5m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

EV/OCF
Enterprise Value to OCF

-4.5
Current
-4.7
Median
6
Industry
Higher than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-4.5
=
Enterprise Value
82.6m EUR
/
Operating Cash Flow
-18.2m EUR
All Countries
Close
 
FR
M
Maat Pharma SA
PAR:MAAT
Average EV/OCF: 23.3
Negative Multiple: -4.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -236 051.4
US
Abbvie Inc
NYSE:ABBV
21.3
US
Amgen Inc
NASDAQ:AMGN
28.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -128.2
US
Gilead Sciences Inc
NASDAQ:GILD
11
US
E
Epizyme Inc
F:EPE
Negative Multiple: -477
AU
CSL Ltd
ASX:CSL
35.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -74.6
NL
argenx SE
XBRU:ARGX
Negative Multiple: -126.8

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More